Zhang · American journal of translational research 2025 · case-control study · n=140

Expression of transient receptor potential vanilloid type 1 (TRPV1) in colonic mucosa of patients with irritable bowel syndrome.

Cited 2 times in the scientific literature.

Level 4 - case-series / case-control

Case-control study comparing tissue biopsies between patients and healthy controls

PubMed 40385026 · doi:10.62347/CUXA2243 · record verified 2026-08-28

What was done

Colonic mucosal biopsies were obtained during colonoscopy from 80 patients diagnosed with irritable bowel syndrome (IBS) and 60 healthy controls recruited between 2013 and 2017 at a single hospital. All participants had normal colonoscopies. Paraffin-embedded tissue sections were evaluated using immunohistochemistry to quantify TRPV1 receptor expression. Researchers analyzed correlations between TRPV1 expression levels and clinical symptom scores, IBS subtypes, patient sex, and biopsy location (ascending vs. descending colon).

What was found

TRPV1 mucosal expression was significantly higher in IBS patients (0.8, range 0–8.4) compared to healthy controls (0.4, range 0–1; P = 0.023). TRPV1 expression demonstrated a strong positive correlation with IBS symptom severity (r = 0.772, P < 0.001). No statistically significant differences in TRPV1 expression were observed across IBS clinical subgroups (P = 0.938), between male (1.0, range 0–7.2) and female (0.8, range 0–8.4) patients (P = 0.871), or between ascending and descending colon mucosa (P > 0.050). Symptom scores did not differ significantly between males (4.0, range 2–9.5) and females (3.75, range 2.0–11.5).

Why it matters

The findings support the role of TRPV1 receptor upregulation in colonic mucosa as a correlate of symptom severity in IBS, independent of disease subtype or patient sex.

Limits

This is a single-center observational case-control study with a modest sample size (n = 140), preventing causal conclusions. Measurements relied solely on immunohistochemical grading without functional electrophysiological validation, and the abstract does not report adjustment for dietary factors, medication use, or psychological comorbidities.

Cited by